Scynexis (SCYX) Research & Development (2013 - 2026)

Scynexis (SCYX) reported Research & Development of $12.4 million for Q1 2026, up 140.25% on a YoY basis from $5.1 million in Q1 2025, and up 171.75% quarter-over-quarter from $4.5 million in Q4 2025.

Scynexis (SCYX) Research & Development (2013 - 2026) Analysis & Trends

Scynexis has reported Research & Development for 14 years, with the latest figure at $12.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Research & Development rose 140.25% year-over-year to $12.4 million; the trailing twelve-month figure through Mar 2026 stood at $29.5 million (up 21.18% YoY), and the FY2025 full-year result was $22.3 million, down 15.62% from the prior year.
  • Research & Development for Q1 2026 stood at $12.4 million, up from $4.5 million in the prior quarter.
  • The five-year high for Research & Development was $12.4 million in Q1 2026, with the low at $4.3 million in Q4 2024.
  • Historically, Research & Development has averaged $7.0 million across 5 years, with a median of $6.8 million in 2023.
  • Annual changes were most pronounced in 2024 — Research & Development slumped 59.25% — and 2026, when it surged 140.25%.
  • Scynexis' Research & Development stood at $7.8 million in 2022, then surged by 34.87% to $10.6 million in 2023, then tumbled by 59.25% to $4.3 million in 2024, then climbed by 5.35% to $4.5 million in 2025, then soared by 171.75% to $12.4 million in 2026.
  • The last three Research & Development figures came in at $12.4 million (Q1 2026), $4.5 million (Q4 2025), and $5.5 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 222.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 180.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 138.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 934,363.43
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 296.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 97.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 103.35 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 46.94 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 39.38 Mn
10 Scynexis 225.23 Mn 165.97 Mn - 12.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.35 Mn
Dec 31, 2025 4.55 Mn
Sep 30, 2025 5.45 Mn
Jun 30, 2025 7.14 Mn
Mar 31, 2025 5.14 Mn
Dec 31, 2024 4.31 Mn
Sep 30, 2024 8.07 Mn
Jun 30, 2024 6.81 Mn
Mar 31, 2024 7.21 Mn
Dec 31, 2023 10.59 Mn
Sep 30, 2023 6.47 Mn
Jun 30, 2023 7.04 Mn
Mar 31, 2023 6.84 Mn
Dec 31, 2022 7.85 Mn
Sep 30, 2022 6.43 Mn
Jun 30, 2022 7.13 Mn
Mar 31, 2022 5.74 Mn
Dec 31, 2021 7.69 Mn
Sep 30, 2021 4.40 Mn
Jun 30, 2021 4.73 Mn